Autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia is associated with IgVH status

Haematologica

Volumn 95, Issue 7, 2010, Pages 1230-1232

  Visco, Carlo ^a   Novella, Ehsabetta ^a   Peotta, Eleonora ^a   Paolini, Rossella ^b   Giaretta, Llaria ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b S MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Autoimmune hemolytic anemia; Chronic lymphocytic leukemia; CLL; IgVH status; Secondary immune thrombocytopenia; Unmutated

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN VARIABLE REGION;

AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW; CASE CONTROL STUDY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA SEQUENCE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOGLOBULIN VARIABLE REGION; LETTER; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SURVIVAL TIME; ANEMIA, HEMOLYTIC, AUTOIMMUNE; COMPLICATION; FACTUAL DATABASE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MORTALITY;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; DATABASES, FACTUAL; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;

EID: 77954474740     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.022079     Document Type: Letter

References (9)

1. Visco C, Giaretta I, Ruggeri M, Madeo D, Tosetto A and Rodeghiero F. Un-mutated IgVH in chronic lymphocytic leukemia is associated with a higher risk of immune thrombocytopenia. Leukemia. 2007; 21 (5): 1092-3.
2. Visco C, Ruggeri M, Laura Evangelista M, Stasi R, Zanotti R, Giaretta I, et al. Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia. Blood. 2008; 111 (3): 1110-6.
3. Hamblin TJ. Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol. 2006; 33 (2): 230-9.
4. Borthakur G, O'Brien S, Wierda WG, Thomas DA, Cortes JE, Giles FJ, et al. Immune anaemias in patients with chronic lym-phocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors. Br J Haematol. 2007; 136 (6): 800-5.
5. Dearden C, Wade R, Else M, Richards S, Milligan D, Hamblin T, et al. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood. 2008; 111 (4): 1820-6.
6. Mauro FR, Foa R, Cerretti R, Giannarelli D, Coluzzi S, Mandelli F, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood. 2000; 95 (9): 2786-92.
7. Barcellini W, Capalbo S, Agostinelli RM, Mauro FR, Ambrosetti A, Calori R, et al. GIMEMA Chronic Lymphocytic Leukemia Group. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia. Haematologica. 2006; 91 (12): 1689-92.
8. Vasconcelos Y, Davi F, Levy V, Oppezzo P, Magnac C, Michel A, et al. Binet's staging system and Vh genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia. J Clin Oncol. 2003; 21 (21): 3928-32.
9. Visco C, Rodeghiero F. Immune thrombocytopenia in lympho-proliferative disorders. Hematol Oncol Clin North Am. 2009; 23 (6): 1261-74.